Safe Anti–PD-1 Therapy Discontinuation in Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
J Immunother Cancer 2021 Oct 01;9(10)xx, GT Gibney, J Zaemes, S Shand, NJ Shah, D Swoboda, K Gardner, A Radfar, V Petronic-Rosic, MJ Reilly, WB Al-Refaie, S Rapisuwon, MB AtkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.